Cellular retinoic acid-binding protein (CRABP)-I has also been demonstrated to be elevated in the cerebrospinal fluid (CSF) of patients with MMD, making it a potential target in the pathogenesis of MMD [19]. The gene discussed is CRABP1; the disease is multiminicore myopathy.